Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
2(50.0%)
4Total
Phase 3(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03946553Completed

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis (MICRORIN)

Role: collaborator

NCT02479568Phase 3Completed

Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases

Role: collaborator

NCT02921217Phase 3Unknown

Effect of a Probiotic on Visceral Fat Accumulation

Role: collaborator

NCT01303432Not ApplicableCompleted

Effect of Yogurts Supplemented With Mobilee on Joint Function in Healthy Individuals With Joint Discomfort

Role: collaborator

NCT01528631Not ApplicableCompleted

The Effects of D-Fagomine on Glycaemic Response to Sucrose in Men

Role: collaborator

All 5 trials loaded